First Trust Advisors LP Reduces Holdings in Option Care Health, Inc. $OPCH

Key Points

• First Trust Advisors LP cut its Option Care Health stake by 53% in the first quarter, selling 43,153 shares and retaining 38,226 shares valued at approximately $1.03 million. Institutional investors collectively own 98.05% of the company.
• Analyst sentiment is mixed, with seven Buy ratings, six Holds and one Sell. The consensus rating is Hold, with an average price target of $29.92, although several firms recently lowered their targets.
• Option Care Health beat quarterly expectations, reporting $0.45 in adjusted EPS versus $0.43 expected and revenue of $1.44 billion versus $1.42 billion estimated. Revenue increased 1.9% year over year, while the stock opened at $24.50.

First Trust Advisors LP lowered its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 53.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 38,226 shares of the company's stock after selling 43,153 shares during the period. First Trust Advisors LP's holdings in Option Care Health were worth $1,029,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Cornerstone Investment Partners LLC lifted its stake in Option Care Health by 3.4% in the 4th quarter. Cornerstone Investment Partners LLC now owns 9,773 shares of the company's stock valued at $311,000 after buying an additional 318 shares in the last quarter. UMB Bank n.a. increased its position in Option Care Health by 23.5% during the fourth quarter. UMB Bank n.a. now owns 1,715 shares of the company's stock worth $55,000 after buying an additional 326 shares in the last quarter. Fifth Third Bancorp raised its holdings in shares of Option Care Health by 21.9% in the fourth quarter. Fifth Third Bancorp now owns 2,328 shares of the company's stock worth $74,000 after acquiring an additional 419 shares during the last quarter. Andina Capital Management LLC raised its holdings in shares of Option Care Health by 2.6% in the fourth quarter. Andina Capital Management LLC now owns 16,320 shares of the company's stock worth $520,000 after acquiring an additional 419 shares during the last quarter. Finally, ProShare Advisors LLC lifted its position in shares of Option Care Health by 1.3% in the fourth quarter. ProShare Advisors LLC now owns 35,533 shares of the company's stock valued at $1,132,000 after acquiring an additional 444 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Analyst Ratings Changes

A number of research firms have issued reports on OPCH. TD Cowen reduced their target price on shares of Option Care Health from $37.00 to $23.00 and set a "hold" rating on the stock in a report on Friday, May 1st. Truist Financial set a $30.00 price target on shares of Option Care Health in a report on Friday, May 1st. Wall Street Zen raised shares of Option Care Health from a "hold" rating to a "buy" rating in a research note on Saturday, August 1st. The Goldman Sachs Group began coverage on shares of Option Care Health in a research note on Monday, June 8th. They set a "neutral" rating and a $22.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a $24.00 target price (down from $26.00) on shares of Option Care Health in a research report on Thursday, July 30th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $29.92.

Option Care Health Price Performance

OPCH opened at $24.50 on Tuesday. Option Care Health, Inc. has a 1 year low of $18.01 and a 1 year high of $36.80. The company's 50 day simple moving average is $21.81 and its 200 day simple moving average is $26.26. The stock has a market capitalization of $3.67 billion, a PE ratio of 18.42, a P/E/G ratio of 1.38 and a beta of 0.65. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.43 by $0.02. The firm had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.42 billion. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. Option Care Health's revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.41 earnings per share. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. As a group, sell-side analysts expect that Option Care Health, Inc. will post 1.69 EPS for the current year.

About Option Care Health

Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source